ࡱ> Root EntryRoot EntrypT(x'FileHeaderhDocInfoUBodyText M(xOM(x HwpSummaryInformation.MPrvImage 7 PrvTextDocOptions pT(xpT(xScripts pT(xpT(xJScriptVersion o DefaultJScriptl_LinkDocp  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLNOPQRSTVWXYZ[\]^_`abcdefgijkmnqrstuvwxz{|}~8] <\><3D Bioprinter @ Regenerative medicine (XY)> <\Դ><The core of regenerative medicine is cell survival rate, Structural recapitulation and biomaterials. ROKIT HEALTHCARE s 3D Bioprinter, INVIVO provides the convergence of technology, which required by regenerative medicine and tissue engineering, to develop a fully functional engineered organ that is immediately applicable to a clinical settings. This talk will introduce the present and future of therapeutic methods with the use of 3D bioprinter that covers various medical applications; plastic surgery for dermal regeneration, orthopedic surgery, cartilage regeneration, ophthalmology for treatment of blindness, and cardiology surgery for treatment of myocardial infarction especially in bioink. In addition, the cell-based technology enables mass production and is able to become a human-cell culture derived extracellular matrixbio-ink, which provides an environment that stem cells can best differentiate into desired target cell type. > <\Ԑ><>GIF89aɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!, H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ JѣH*]ʴӧPJJիXjʵׯ`ÊKYv`iTݵtʥ-[uẃ+^̸1Ð#KL˘쐳X,ƥ [`Q+Z`BEiӥﺅWnn[&肤KXds^Oǫpyc%>˟8˾ <ɖ[I``zbtMx~UyxGETG]܆8 i/*tG)Rhr8bHZvC vQ_r Qg9iވLXr8[)$"k ن0j>Hdi-YCR>~Mٙ\y9btܖ`:6Z uXYcpVG v"f)l噊Qivh( :'y(hƉ+q+tYщg\V^i Jz花*ʨ" H$E)f6(bK<*HkFߘZ{^*jJkq:lz8F^ce;YvkØf7&dƺBK򨽆#hl3 j™&͛̕L9&r /k9)0m)%dZn`,^z:2Jժ7lݿ]vcy ntQ 5l+d-LF}"nkX qn-tMzF] ߸a$,,x~wUN%&Och貢]-|*Y%&T.%ՎwWbZB9/}ҭrad2&E^r֚Ҷ5 âӍ799 :1I`_$;Eo\a*E qx0PNB Ҝ1Xɢ8n,WDϖ7.OrCF.n_-8%)qc֒u˅`bRC.gAiN$L# $ä K%9z\-2nRPL)% V2|giOͲ Nr;OWݱY3nR"%je~JO2UKE)M}'|$0l3&= nu߹Eީ d4GUgr>9&t濬)Q}Q_$DSQ$b@^2C Q-PUxy/B3)&jMxjte2~Z}f7Қ3%he?i'v~e-I] ٯviL}nTۓ(f/Y\,kTXzux {.(UjYf6Dئboy-"VPm -qc9VoZ[tl=h'A6(E{ _~{[u0 J1- Kߊ(؂UaXwoG.: \߼*w\&ʆP(1ث셋c##FFաuQe/ylB8Ytjzl?62C}LkM g2wm r&y;󵂹?ͰLߌѮl&,G7~`d$Wzt3=iVĐN]QkXӫ4kE:&W: 5=N׶6v_ء^v}rcc†3`mbESt=qfѧo՜gKoFkn涷]Rp[7YZFW܆;'N[ϸ7{ GN(OW0gNs;`a``a`0x  t  ajou2010D 2 10| ”| $ 2:36:28rainm-8, 5, 8, 1630 WIN32LEWindows_Unknown_Version@m @OM(x@W=oA};>'@H#HQ(P  (2"j#YHD))i0w> 洵3};3cNٱ<-M90g+wm#TVu^;/sV3'#1#2e#Ỉ̱LDf5ٯx JF43>̚歺<~"#G,-\pF]g@иA6ķ /L. ǚo 5SVq%CEN6d[ y\ 풿kA?;7csZAKɕ[ha<0)ܙC;K<,ۈ gPl3x4l,fw{[vgyޛm`9yaR#'[ӄ\4p1 F2vFvj;%RۖFeL7bjZvQ ng}gyQk&̐er1c"JcAE{6l44^>(f/ DUy_VC 1-)lMzfJT3Kuzmn2OϪuMƉQe4gVJt-Cn)␸Cջ'.)(~lն0AV {;z2+rӛ$vAbu/_tUꚿOxU\T_YZ~W~W]Z72U^Wr?o5 HWP Document Fileu@DO 6C,H,#GB!k0~ 6*7=M*Z:ҙ#?*?ӿT@Y~X+mj3'm[v|:j)%C$Mϼ5#cd߈ink. In addition, the cell-based technology enables mass production and is able to become a human-cell culture derived extracellular matrixbio-ink, which provides an environment that stem cells can best differentiate into desired target cell type. > <\Ԑ><>W]hU>3;i6vk6TiKb4c( (dwgY` }ARh֗&/}ćVϝ3ܙ{wsP7f$ yuj&89W0v^.=֍ko^Ƭ:KwafG+H*!G>ּP&~Y(aV-iw۷J/ NA/aI !~147 U|!{6o0<228V%P§r<$G`eG!rOsO5V}Fu-[f4rpr[qz3yBAM@YXdrx{,೺ xsxF%bA쿊*j]㑢Z/ "yQ6˸ Y5S@qaf?" oF&e8shqpPf[e棪Xi"J=D2[e@? ߖw{J IJsJUyNJ +6qU%>Vg8F 󡀈C/O1`bmb0E^G%\'YRbBZ߂@*ELsUdE k!bAcdW+pڑvko96M;UQQVhKْ>7%D$1m[׹ϟR:ă:Ϣ'o?:uB}:uʓ:e: u9x ʎzki=OΞV׳gϞWNLvx͆)Y>W2StqxN)靮Nt& M|=\,a,CO\wޮdl⟕VNQ=3Ӗ]4хLbjBRH誖b h$-FQK&X-MLl,H%&,.B~:HG{i% \<&ӈKg`bRөfFY5UwŒ<)%T=90g]ꠒZ(4;֌6ܚiNވ;/RleE٠&rΦleSScgIٴ)MSq.t[ H#]_kq{ʔ6 2ITrN8/L,8e7bjeR'%W8(pu7KSW xxgcLV0"pt~U